BFM
IRWD icon

Boothbay Fund Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Boothbay Fund Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,970
Closed -$57.5K – 1582
2024
Q4 		$57.5K Buy
+12,970
New +$52.6K ﹤0.01% 1340
2022
Q3 		– Sell
-10,354
Closed -$119K – 2414
2022
Q2 		$119K Buy
+10,354
New +$122K ﹤0.01% 1938
2021
Q4 		– Sell
-18,929
Closed -$247K – 2032
2021
Q3 		$247K Buy
+18,929
New +$245K 0.01% 1444
2021
Q2 		– Sell
-14,627
Closed -$164K – 1972
2021
Q1 		$164K Buy
+14,627
New +$155K 0.01% 1400
2018
Q2 		– Sell
-16,767
Closed -$217K – 815
2018
Q1 		$217K Buy
+16,767
New +$209K 0.03% 585

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Boothbay Fund Management's IRWD Position: Q1 2025 in Review

Boothbay Fund Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 12,970 shares — an estimated $57.5K sold.

Boothbay Fund Management first reported a position in IRWD in Q1 2018 and held it in 5 quarters. The position peaked at $247K in Q3 2021. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Boothbay Fund Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 12,970 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $57.5K.
  • Boothbay Fund Management first reported a position in Ironwood Pharmaceuticals in Q1 2018 and held it in 5 quarters.
  • Boothbay Fund Management's Ironwood Pharmaceuticals position peaked at $247K in Q3 2021.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.